Cell & Gene
An AGT Video Series
Companies like AGT are doing groundbreaking research and developing innovative ways to combat diseases. This series of videos will take an inside look at how gene and cell therapy technologies work, what it is like to be part of an innovative gene and cell therapy company, and what these technologies mean for the future of medicine.
An AGT Video Series: Cell and Gene Therapy Explained
Video Series Overview
Following an explosive few years in cell and gene therapy drug development and the introduction of the first cures to cancer the world has ever seen, we’re closer than ever to finding legitimate therapies to eradicate HIV, cancers, and rare diseases. Companies like AGT are doing groundbreaking research and developing innovative ways to combat diseases. Yet, without utilizing evolving technologies and a talented workforce, efforts to develop cures can be slowed. AGT recognizes these factors and works to accelerate its science, driven by the mission to end suffering and early death from harmful human diseases.
This series of videos will take an inside look at how gene and cell therapy technologies work and are harnessed by biotechnology companies like AGT, what it is like to be part of an innovative gene and cell therapy company, and what these technologies mean for the future of medicine and pharmaceuticals.
These videos will explore the experiences of AGT’s top executives on both a practical and personal level to give people who may be interested in the industry a realistic idea of what to expect.
Subscribe to Our Newsletter
Subscribe to our newsletter to keep up to date with all the latest news about AGT!
Cell and Gene Therapy Approach
Jeff Galvin, CEO of AGT
Gene therapy is accelerating at an incredibly fast and impressive rate. AGT is at the forefront of this progress, fueling the gene therapy market.
Cell Therapy Manufacturing
C. David Pauza, Ph.D., CSO of AGT
This video explains the ins and outs of cell therapy. Dr. C. David Pauza, Chief Science Officer of American Gene Technologies, explains how one tiny dot on a cell, a virus, can kill a person, but this dot can be changed from the infectious root of disease into curative genetic medicine.
Progression of a Gene Therapy Company
Jeff Galvin, CEO and Irene Tennant, VP of AGT
In this video, Jeff Galvin and Irene Tennant have a conversation about their work at American Gene Technologies (AGT), a gene therapy company, built to cure diseases that were previously thought of as incurable. The mission statement of the company is to “reduce human suffering and death from serious human diseases.”
Using Gene Therapy to Cure Diseases
Irene Tennant, VP of AGT
Irene Tennant, the head of clinical development and regulatory affairs at AGT, speaks about her role in the development of gene and cell therapies to treat human diseases. She works to progress potential therapies into the clinic, and ultimately to the bedsides of thousands of people.
About Gene Therapy
Jeff Galvin, CEO of AGT
In this video, Jeff Galvin explains how American Gene Technologies (AGT) uses genetic modifications in the body to change how viral diseases interact with the immune system.